Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $1,619,345 (100.0% shares, 0.0% debt)

Holdings (36)

BN BROOKFIELD CORP 9.6%
Value ($000) $155,675 Shares 3,880,230 Est. Cost $22.16 Unrealized +1.0%
ASML ASML HOLDING N V 9.2%
Value ($000) $149,688 Shares 197,760 Est. Cost $654.82 Unrealized
CRM SALESFORCE.COM, INC. 8.6%
Value ($000) $139,596 Shares 530,500 Est. Cost $193.03 Unrealized +15.8%
SPRO SPERO THERAPEUTICS INC 7.6%
Value ($000) $123,387 Shares 468,902 Est. Cost $11.41 Unrealized -89.6%
LANZATECH GLOBAL INC 4.9%
Value ($000) $79,549 Shares 15,814,845 Est. Cost $3.88 Unrealized
CORT CORCEPT THERAPEUTICS INC 4.8%
Value ($000) $78,321 Shares 2,411,362 Est. Cost $23.02 Unrealized +19.3%
TSM TAIWAN SEMICONDUCTOR MFG LTD 4.6%
Value ($000) $73,921 Shares 710,780 Est. Cost $96.28 Unrealized
EWTX EDGEWISE THERAPEUTICS INC 4.1%
Value ($000) $66,424 Shares 6,071,703 Est. Cost $30.65 Unrealized -77.1%
CABO CABLE ONE INC 4.1%
Value ($000) $65,902 Shares 118,403 Est. Cost $987.67 Unrealized -44.7%
PCVX VAXCYTE INC 3.3%
Value ($000) $53,066 Shares 845,000 Est. Cost $26.47 Unrealized +96.2%
MIRM MIRUM PHARMACEUTICALS INC 2.7%
Value ($000) $44,280 Shares 1,500,000 Est. Cost $12.27 Unrealized +146.7%
BMRN BIOMARIN PHARMACEUTICAL INC 2.7%
Value ($000) $43,389 Shares 450,000 Est. Cost $84.31 Unrealized +4.9%
PHVS PHARVARIS N V 2.7%
Value ($000) $43,178 Shares 1,539,325 Est. Cost $12.83 Unrealized +57.7%
AAPL APPLE INC 2.6%
Value ($000) $42,638 Shares 221,460 Est. Cost $90.57 Unrealized +101.8%
INSM INSMED INC 2.6%
Value ($000) $41,505 Shares 1,339,304 Est. Cost $23.10 Unrealized +12.2%
CRNX CRINETICS PHARMACEUTICALS IN 2.4%
Value ($000) $39,138 Shares 1,100,000 Est. Cost $19.36 Unrealized +58.4%
BABA ALIBABA GROUP HLDG LTD 2.4%
Value ($000) $38,819 Shares 500,827 Est. Cost $165.09 Unrealized
FOLD AMICUS THERAPEUTICS INC 2.2%
Value ($000) $35,475 Shares 2,500,000 Est. Cost $12.83 Unrealized -11.5%
BLUEPRINT MEDICINES CORP 2.0%
Value ($000) $33,126 Shares 359,126 Est. Cost $59.75 Unrealized
RCKT ROCKET PHARMACEUTICALS INC 1.9%
Value ($000) $31,469 Shares 1,050,000 Est. Cost $28.33 Unrealized -22.1%
FDMT 4D MOLECULAR THERAPEUTICS IN 1.9%
Value ($000) $30,390 Shares 1,500,000 Est. Cost $17.62 Unrealized -25.3%
CARGO THERAPEUTICS INC 1.8%
Value ($000) $28,938 Shares 1,250,000 Est. Cost $23.15 Unrealized
VERVE THERAPEUTICS INC 1.7%
Value ($000) $27,880 Shares 2,000,000 Est. Cost $13.94 Unrealized
BAM BROOKFIELD ASSET MANAGMT LTD 1.6%
Value ($000) $25,195 Shares 627,207 Est. Cost $31.11 Unrealized +1.1%
ALNY ALNYLAM PHARMACEUTICALS INC 1.4%
Value ($000) $22,660 Shares 118,383 Est. Cost $160.04 Unrealized +6.4%
CYMABAY THERAPEUTICS INC 1.3%
Value ($000) $21,258 Shares 900,000 Est. Cost $10.95 Unrealized
SPRUCE BIOSCIENCES INC 1.2%
Value ($000) $19,696 Shares 6,722,336 Est. Cost $17.05 Unrealized
LXEO LEXEO THERAPEUTICS INC 1.1%
Value ($000) $17,551 Shares 1,307,829 Est. Cost $12.42 Unrealized 0.0%
INSP INSPIRE MED SYS INC 0.8%
Value ($000) $13,330 Shares 65,524 Est. Cost $202.35 Unrealized -19.9%
IOBT IO BIOTECH INC 0.7%
Value ($000) $10,804 Shares 5,747,067 Est. Cost $6.26 Unrealized -81.0%
ABCL ABCELLERA BIOLOGICS INC 0.4%
Value ($000) $6,435 Shares 1,126,915 Est. Cost $8.47 Unrealized -45.3%
TMCI TREACE MED CONCEPTS INC 0.3%
Value ($000) $4,590 Shares 360,000 Est. Cost $25.28 Unrealized -60.0%
RALLYBIO CORP 0.3%
Value ($000) $4,225 Shares 1,767,861 Est. Cost $6.73 Unrealized
MQ MARQETA INC 0.2%
Value ($000) $3,082 Shares 441,558 Est. Cost $22.37 Unrealized -73.2%
LAVA THERAPEUTICS NV 0.2%
Value ($000) $2,968 Shares 1,878,194 Est. Cost $15.19 Unrealized
GALECTO INC 0.1%
Value ($000) $1,798 Shares 2,497,791 Est. Cost $12.51 Unrealized